A Study of Ranibizumab Administered Monthly or on an As-needed Basis in Patients With Subfoveal Neovascular Age-related Macular Degeneration (HARBOR)

New York

Great Neck

Lynbrook

Shirley

Rochester

West Mifflin

Pittsburgh

Pittsburgh

Johnstown

Camp Hill

Huntingdon Valley

Philadelphia

Baltimore

Hagerstown

Richmond

Virginia Beach

Charlotte

Asheville

West Columbia

Ladson

Greenville

Augusta

Pensacola

Altamonte Springs

Fort Lauderdale

Palm Beach Gardens

Boynton Beach

Tampa

Tampa

Winter Haven

Fort Myers

Stuart

Nashville

Lexington

Paducah

Columbus

Beachwood

Cincinnati

Indianapolis

Jackson

Milwaukee

Edina

Rapid City

Oak Park

Chicago

St Louis

Shawnee Mission

Wichita

Lincoln

DeSoto

Temple

Houston

The Woodlands

San Antonio

McAllen

Austin

Abilene

Aurora

Golden

Colorado Springs

Casper

Salt Lake City

Phoenix

Tucson

Las Vegas

Los Angeles

Beverly Hills

Torrance

Arcadia

Westlake Village

Poway

Palm Desert

Santa Ana

Ventura

Santa Barbara

Mountain View

San Francisco

San Francisco

Oakland

Campbell

Sacramento

Chico

‘Aiea

Portland

La Jolla

Los Angeles

Danbury

Hamden

New Haven

New London

Portland

Boston

Boston

Worcester

Lawrenceville

New Brunswick

Northfield

Teaneck

Vauxhall